首页|期刊导航|国际肝胆健康（英文）|Recalibrating the evidence level in hepatocellular carcinoma:Integrating efficacy and effectiveness of immunotherapy

Recalibrating the evidence level in hepatocellular carcinoma:Integrating efficacy and effectiveness of immunotherapy

Han Wu Xin-Fei Xu Jia-Hao Law Tian Yang

国际肝胆健康（英文）Issue(4)：27-28,2.

国际肝胆健康（英文）Issue(4)：27-28,2.DOI:10.1016/j.iliver.2025.100200

Recalibrating the evidence level in hepatocellular carcinoma:Integrating efficacy and effectiveness of immunotherapy

Han Wu ¹Xin-Fei Xu ¹Jia-Hao Law ²Tian Yang¹

作者信息

1. Department of Hepatobiliary Surgery,Eastern Hepatobiliary Surgery Hospital,Naval Medical University,Shanghai 200438,China
2. Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,National University of Hospital,Singapore 119074,Singapore
折叠

摘要

引用本文复制引用

Han Wu,Xin-Fei Xu,Jia-Hao Law,Tian Yang..Recalibrating the evidence level in hepatocellular carcinoma:Integrating efficacy and effectiveness of immunotherapy[J].国际肝胆健康（英文）,2025,(4):27-28,2.

国际肝胆健康（英文）

访问量1

下载量0

段落导航